Meet your Executive Committee
| Philippe Bouchard |  |
Professor and Chair,
Department of Endocrinology and Ob Gyn, |
Philippe Bouchard is presently Professor of Medicine, and Chair of The Department of Endocrinology, and Ob Gyn (GEO), at Hospital Saint Antoine, University Paris 6 (UPMC). He is the former Director of EA 1533 “Genetics of Human Reproduction”. Author of more than 300 publications, Philippe Bouchard is former President of the French Endocrine Society, the European Society of Gynaecology and the French Society for Reproductive Medicine. His research is related to gynaecological endocrinology and genetics. He is a corresponding member of the National Academy of Medicine, Doctor honoris causa of the University of Liege, and past President of the Board of Endocrinology at the French Ministry of Education (CNU). |
|---|---|---|---|
| Paolo Beck Peccoz |  |
Paolo Beck-Peccoz Tel: +39 02 50320606 |
Paolo Beck-Peccoz graduated (MD) from the University of Turin and later specialised in endocrinology and Internal medicine. He joined the University of Milan as an Intern and rose to the position of Director, 2nd school of specialisation in Endocrinology. He was the Editor-in Chief of the European Journal of Endocrinology from 1998-2007. He is on the Editorial Boards of various journals including Thyroid (1994 to present) and PLOS Medicine (2004 to present). He has been Secretary, Italian Society of Endocrinology and has been a member of its Executive Committee. He has also held memberships of the Executive memberships of the EFES and the European thyroid Association. He has been on the Programme organising committees (POC) of the International Congress of Endocrinology (Sydney 2000) and member of the POC of the last 4 European Congresses of Endocrinology. He has been an Invited speaker and has also chaired various National and International Meetings. He is also the winner of the ETA Merck Prize 2006. He has collaborated internationally with various research institutions all over the world. He has published more than 400 papers in various journals and books. |
 |
Professor Barbara Jarzab Tel: +48322789339 |
Barbara Jarzab was born in 1952. She is an endocrinologist and nuclear medicine specialist, Head of Nuclear Medicine and Endocrine Oncology Department at Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland; a comprehensive cancer center and research institute that takes care for Silesian patients, an industrial part of Poland with 5 million inhabitants. Professor Jarzab’s areas of research involvement are functional genomics of endocrine tumours with focus on gene expression profiling of thyroid cancer and genetic predisposition to endocrine disease (thyroid cancer, pheochromocytomas, Graves disease). Clinical activity focuses on radioiodine therapy of differentiated thyroid cancer and benign thyroid disease, radiopeptide imaging and therapy of neuroendocrine tumors, new methods of diagnosis and therapy of progressive endocrine gland cancer (thyroid ca, parathyroid ca, adrenal ca). In the past she was involved in experimental neurendocrinology, focusing on sexual brain differentiation. She has published over 100 papers in peer-reviewed journals and serves as a reviewer for international journals e.g. Eur J Endocrinol, End Rel Cancer, Mol Cell Endocrinol, Exp Clin Endocrinol Diab. She is Co-Editor-in-Chief of a new thyroid related journal, Thyroid Research. In years 2006-2009 she was a member of the Executive Committee of European Thyroid Association. In 2008 she was appointed Secretary of the European Thyroid Association Cancer Network. She is the President of Polish Group of Endocrine Tumors. |
|
| Aart J van der Lely |  |
Erasmus MC Tel +31 10 703 2862 |
Aart Jan van der Lely serves as Chief and Professor of Clinical Endocrinology at the Department of Medicine, Section of Endocrinology and Head of the Clinical Research Unit at the Erasmus MC in Rotterdam, The Netherlands. He is also Scientific Director of the Erasmus Institute of Neuro-endocrinology (ERINE) in Rotterdam. His areas of research are neuro-endocrine disorders, pituitary disease, clinical and basic aspects of the role of gut hormones in metabolism. Dr Van der Lely has published many papers and book chapters and he serves as continental editor of Clinical Endocrinology (Oxford) and on the editorial board of the Journal of Endocrinological Investigation, Clinical Interventions in Aging, Journal of Clinical Endocrinology and Metabolism and Nature Clinical Endocrinology and Metabolism. He is president of the Dutch Endocrine Society and secretary of the European Union of Medical Specialists (UEMS), section of endocrinology. In that position he is also responsible as secretary for the CME accreditation via UEMS in the field of Endocrinology. |
| Wiebke Arlt |  |
Wiebke Arlt – Tel: +44 121 4158716 |
Wiebke Arlt is 43 years of age and fell for Endocrinology as a medical student, followed by clinical and scientific training in Germany and the USA. At present, she serves as Professor of Medicine and Head of the Centre for Endocrinology, Diabetes and Metabolism at the University of Birmingham, United Kingdom. She is a Consultant Endocrinologist at the University Hospital Birmingham, the Birmingham Women’s Hospital and the Birmingham Children’s Hospital. She is a committed clinician scientist and heads a research group working on basic and clinical aspects of adrenal and gonadal disorders, with a particular focus on steroid endocrinology. She is a steering committee member of the European Network for the Study of Adrenal Tumours, ENS@T, and the FP7 European Collaborative Network on Disordered Sex Development, EuroDSD. She is an editorial board member of the European Journal of Endocrinology, Clinical Endocrinology, Journal of Endocrinology and Journal of Clinical Endocrinology & Metabolism. She serves on several committees of the Society for Endocrinology United Kingdom and the Programme Organising Committees for the ECE meetings 2005 Gothenburg and 2010 Prague. She represents the European Society of Endocrinology as a POC member for the ICE meeting 2010 Kyoto. |
 |
Senior consultant in Endocrinology |
Pia Burman is Senior consultant and Associate professor of Medicine at the Department of Endocrinology, University Hospital, Malmö-Lund, Sweden. After presenting her PhD thesis in 1991, describing the identification of the parietalcell antigen as being H,K-ATPase, she developed an interest in pituitary disease, in particular GH deficiency and excess. She has published 66 papers in peer-reviewed journals, including reports on the effects of GH on quality of life, on neurotransmittors, and the seminal paper on gender differences in response to treatment with GH. In 1996 she was recruited to Pharmacia, where she in the capacity of Global Medical Director for Endocrine Care was responsible for developing the clinical program for Genotropin and subsequently Somavert, interacted with FDA and ENEA, and had a key role in developing the scientific programs for International Symposia. In 2004 Pia returned to academia. She is an active member of the Swedish Pituitary Study group and the Swedish KIMS Board. She is also a member of the Swedish Endocrine Society, Swedish Medical Society, Endocrine Society, and KIMS International Committee. |
|
| Justo Castaño |  |
Dr. Justo P. Castaño Phone: +34 957 21 22 56 |
Justo P. Castaño is Professor of Cell Biology at the University of Cordoba, Spain. Dr. Castaño is 45 years of age. He graduated and obtained his PhD on Biological Sciences at the University of Cordoba and completed his postdoctoral training at the Medical University of South Carolina (Charleston, USA). He currently serves as Head of the Hormones and Cancer Research Group of the Department of Cell Biology, Physiology and Immunology of the University of Cordoba. His research over the last two decades has been focused on the regulation of pituitary cell types by somatostatin, cortistatin, GHRH, ghrelin, and kisspeptins, and on the molecular biology of these peptides, their receptors and signaling pathways in health and disease. More recently, these studies have been directed toward elucidating the presence and functional relevance of different types of neuropeptides and their receptors on human pituitary adenomas and in cancer. Dr. Castaño has published over 75 scientific articles and 30 book chapters and has contributed over 190 congress communications. He serves as Scientific Editor for the Journal of Molecular Endocrinology and on the editorial board of the Journal of Endocrinology, Molecular and Cellular Endocrinology, and Journal of Alzheimer Disease, and has served as ad hoc reviewer for several journals, including Trends in Endocrinology and Metabolism, Journal of Clinical Endocrinology and Metabolism, Endocrinology, Endocrine Related Cancer, etc. He is President of the Iberian Society for Comparative Endocrinology, has served as member of the POC of the Rio de Janeiro ICE 2008 and the Liege ENEA Meeting 2010, and has co-chaired the Basic Endocrinology Courses of the ESE held in Cordoba (2006) and Turin (2009). He has directed 8 Doctoral Thesis. |
| Andrea Giustina |  |
Endocrine Service Montichiari Hospital via Ciotti 154 25018 Montichiari (Italy) Tel: +390309963480 Fax: +390309963477 a.giustina@libero.it |
Andrea Giustina graduated in Medicine in 1986, postgraduated in Internal Medicine in 1991 and in Endocrinology in 1996. Assistant Professor in Endocrinology from 1991 and Associate Professor of Internal Medicine at the University of Brescia (Italy) from 2001. Full Professor of Internal Medicine from 2005, and from 2007 has been at the University of Brescia and is currently, head of Endocrine Service, Brescia-Montichiari Hospital. Andrea Giustina has published more than 350 original papers (220 on peer reviewed international journals) in the area of bone metabolism, basic and clinical neuroendocrinology, cardiovascular and skeletal endocrinology and diabetes. Previously member of the Editorial Board of JCE&M and Clinical Endocrinology, and is currently Editor of Pituitary and Reviewing Editor of the Journal of Endocrinological Investigation. Andrea Giustina has previously been a member of the Journal managing subcommittee of the Endocrine Society and is currently chairman of the Clinical Initiatives Committee of the Pituitary Society. |
 |
Institute of Reproductive and Developmental Biology, |
Ilpo Huhtaniemi received his MD and PhD at University of Helsinki, Finland, did postdoctoral training in USA (UC San Francisco and NIH, Bethesda), and has been on sabbatical leave in Germany, USA and Scotland. He held 1986-2002 the post of Professor and Chairman of Physiology at University of Turku, Finland. He moved in 2002 to UK to a Chair in Reproductive Endocrinology at Imperial College London. He has received several national and international honours, including a fellowship of The Academy of Medical Sciences (UK) and a Doctor Honoris Causa at the Medical University Lodz, Poland. He has been the Chief Managing Editor of Mol Cell Endocrinol since 1999, has served in the Editorial Board of Endocrinology and Endocr Rev and is/has been the Editor or Editorial Board Member of several other scientific journals (e.g. Eur J Endocrinol, Clin Endocrinol, Hum Reprod Update, J Endocrinol, Mol Hum Reprod, Reproduction, Asian J Androl). He has extensive experience as Official of international scientific organisations (e.g. Past President of International Society of Andrology). His research interests include clinical and basic reproductive endocrinology, in particular the function of gonadotrophins. He also has long-term interests in the development of male contraception, hormone-dependent cancer, and the endocrinology of ageing. He has authored about 600 peer-reviewed research articles. |
|
| Martin Reincke |  |
Medizinische Klinik – Innenstadt Tel.: +49-89-51602100 |
Martin Reincke is Professor of Medicine at the Medizinische Klinik Innenstadt, University of Munich, Germany. He received his MD from the University of Cologne, and from 1991–2, he worked as a research fellow in the laboratory of Dr George Chrousos (National Institutes of Health, Bethesda, USA). Professor Reincke qualified in Internal Medicine and Endocrinology at the University of Wuerzburg, Germany, and in 1998, he became Professor of Medicine and Head of Endocrinology and Diabetology at the Albert-Ludwigs University in Freiburg, Germany. Currently, Professor Reincke is the Chair of Endocrinology and Diabetology and Director of the Medizinischen Klinik – Innenstadt at Ludwig-Maximilians University in Munich. In addition to his clinical duties, Professor Reincke has performed research in the areas of hormone substitution therapy, androgen and estrogen metabolism, molecular biology of pituitary adenomas, adrenocortical tumorigenesis and mineralocorticoid hypertension. Since 2006, he has served as a teaching Dean for the Faculty of Medicine and in April 2007, he was appointed acting director of the Medizinischen Poliklinik – Innenstadt at Ludwig-Maximilians University. Professor Reincke has published more than 180 manuscripts and contributed to more than 50 textbooks. |
| Hans Romijn |  |
Department of Medicine Tel: +31 (0)20 5662171 |
Hans Romijn (1955) attended medical school at the University of Amsterdam and was subsequently trained in internal medicine in the Academic Medical Center, University of Amsterdam, followed by fellowships in intensive care medicine and endocrinology (under supervision of Prof. Dr. W.M. Wiersinga). In 1990 he obtained the degree of Ph D. In 1997 he was appointed as professor in clinical nutrition and in 1998 as professor in endocrinology and chairman of the Department of Endocrinology, Leiden University Medical Center (LUMC). In 2004 he was appointed as chairman of medicine and director of the residency training program in internal medicine at the LUMC. In 2010 he was appointed as professor of medicine and chairman of the Departments and Division of Medicine, Academic Medical Center in Amsterdam. The focus of his research group is on long term effects of pituitary diseases and on neuro-endocrine regulation of metabolism. He has published over 450 papers in these areas in peer-reviewed journals. He was the president of the Dutch Endocrine Society from 2002-2006. |
| Richard Ross |  |
University of Sheffield, Tel: + 44 (0)114 2712386, |
Richard Ross trained at The Royal London Hospital (1974-1979) and in endocrinology at St Bartholomew’s Hospital, London (1983-1988). He is Head of Unit for Diabetes & Endocrinology and faculty Academic Lead for Innovation at the University of Sheffield. His research interests are in pituitary disease and focus on optimising pituitary hormone replacement. He has a particular interest in innovation and is a founding director of two university spin-out companies, Asterion Ltd and Diurnal Ltd, developing new growth hormone and steroid replacement therapies, respectively. He has served and serves on the editorial boards of Clinical Endocrinology, Growth & Growth Factors, Hormones, and J Clin Endocrinol Metab. He was a council member for the Society of Endocrinology, editor of the Endocrinologist, and member of the Bioscientifica board. He serves on the Society for Endocrinology public engagement committee and nominations committee, the Endocrine Society Hormone Foundation, and is a council member of the Growth Hormone Research Society. |